A correlation between immunoexpression of CD44, α-SMA and CD68+ cells in IgA-nephropathy and in mesangial proliferative IgA-negative glomerulonephritis

Polish Journal of Pathology

Volumn 53, Issue 3, 2002, Pages 155-162

  Wa̧growska Danilewicz, Malstrok gorzata ^a   Danilewicz, Marian ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CD68 ANTIGEN; HERMES ANTIGEN; IMMUNOGLOBULIN A;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; MACROPHAGE; MALE;

ACTINS; ANTIGENS, CD; ANTIGENS, CD44; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY;

EID: 0036407656     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of muscle specific actin in glomerulonephritis. Kidney Int 1992, 41, 1134-1142.
2. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 1990, 61, 1303-1313.
3. Benz PS, Fan X, Wuthrich RP: Enhanced tubular epithelial CD44 expression in MRL-Ipr lupus nephritis. Kidney Int 1996, 50, 156-163.
4. Borland G, Ross JA, Guy K: Forms and functions of CD44. Immunology 1998, 93, 139-148.
5. Carter WG, Wayner EA: Characterisation of the class HI collagen receptor, aphosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 1988, 263, 4193-4201.
6. Churg J, Bernstein J, Glassock RJ: Renal disease. Classification and Atlas of Glomerular Diseases. Igaku-Shoin, New York, Tokyo 1995, 181-184.
7. Daniel L, Sichez H, Giorgi R, Dussol B, Figarella-Branger D, Peiissier J-F, Berland Y: Tubular lesions and tubular cell adhesion molecules for prognosis of lupus nephritis. Kidney Int 2001, 60, 2215-2221.
8. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 193, 122, 103-111.
9. Emancipator SN: IgA nephropathy: Morphologic expression and pathogenesis. Am J Kidney Dis 1994, 23, 451-462.
10. Feusi E, Sun L, Sibalic A, Beck-Schimmer B, Oertli B, Wuthrich RP: Enhanced hyaluronan synthesis in MRL-Fas(Ipr) kidney: Role of cytokines. Nephron 1999, 83, 66-73.
11. Goumenos DS, Brown CB, Shortland J, El Nahas M: Myofibroblasts, predictors of progression in IgA nephropathy. Nephrol Dial Transplant 1994, 9, 1418-1425.
12. Hewitson TD, Becker GJ: Interstitial myofibroblasts in IgA glomerulonephritis. Am J Nephrol 1995, 15, 111-117.
13. Hodge-Dufour J, Noble PW, Horton MR, Bao C, Wysoka M, Burdick MD, Strieter RM, Trinchieri G, Pure E: Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol 1997, 159, 2492-2500.
14. Hoffman M, Rudy W, Gunthert U, Zimmer SG, Zawadski V, Zoller M, Lichtner RB, Herrlich P, Ponta H: A link between ras and metastatic behaviour of tumor cells: Ras induces CD44 promotor activity and leads to low-level expression of metastatic-specific variants of CD44 in CREF cells. Cancer Res 1993, 53, 1516-1521.
15. Johnson RJ, Ida H, Alpers CE: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J Clin Invest 1991, 87, 847-858.
16. Jun Z, Hill PA, Lan HY, Foti R, Mu W, Atkins RC, Nikolic-Paterson DJ: CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis. Clin Exp Immunol 1997, 108, 69-77.
17. Lake FR, Noble PW, Henson PM, Riches DW: Functional switching of macrophage responses to tumor necrosis factor-α (TNF-α) by interferons. J Clin Invest 1996, 93, 1661-1669.
18. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 1993, 54, 271-335.
19. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Gunthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994, 124, 71-82.
20. MacPherson BR, Leslie KO, Lizaso KV, Schwartz JE: Contractile cells of the kidney in primary glomerular disorders: An immunohistochemical study using an anti-alpha-smooth muscle actin monoclonal antibody. Hum Pathol 1993, 24, 710-716.
21. McKee CM, Lowenstein CJ, Horton MR, Wu J, Bao C, Chin BY, Choi AM, Noble PW: Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear fragment κB-dependent mechanism. J Biol Chem 1997, 272, 8013-8018.
22. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: The role of HA size and CD44. J Clin Invest 1996, 98, 2403-2413.
23. Mijake K, Underhill CB, Lesley J, Kincade PW: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990, 172, 69-75.
24. Muchaneta-Kubara EC, El Nahas AM: Myofibroblast phenotypes expression in experimental renal scaring. Nephrol Dial Transplant 1997, 12, 904-915.
25. Nikolic-Paterson DJ, Jun Z, Tesch GH, Lan HY, Foti R, Atkins RC: De novo CD44 expression by proliferating mesangial cells in rat anti-Thy-1 nephritis. J Am Soc Nephrol 1996, 7, 1006-1014.
26. Oba S, Kimura K, Suzuki N, Mise N, Tojo A, Miyashita K, Konno Y, Hirata Y, Goto A, Omata M: Relevance of periglomerular myofibroblasts in progression of human glomerulonephritis. Am J Kidney Dis 1998, 32, 419-425.
27. Oertli B, Fan X, Wuthrich RP: Characterization of CD44-mediated hyaluronan binding by renal tubular epithelial cells. Nephrol Dial Transplant 1998, 13, 271-278.
28. Roy-Chaudhury P, Khong TF, Williams JH, Haites NE, Wu B, Simpson JG, Power DA: CD44 in glomerulonephritis: Expression in human renal biopsies, the Th 1.1 model, and by cultured mesangial cells. Kidney Int 1996, 50, 272-281.
29. Sibalic V, Fan X, Loffing J, Wuthrich RP: Upregulated renal tubular CD44, hyaluronan, and osteopontin in kdkd mice with interstitial nephritis. Neprol Dial Transplant 1997, 12, 1344-1353.
30. Takazoe K, Foti R, Tesch GH, Hurst LA, Lan HY, Atkins RC, Nikolic-Paterson DJ: Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease. Clin Exp Immunol 2000, 121, 523-532.
31. Tesch GH, Yang N, Yu H, Lan HY, Foti R, Chadban SJ, Atkins RC, Nikolic-Paterson DJ: Intrinsic renal cells are the major source of interleukin-1β synthesis in normal and diseased rat kidney. Nephrol Dial Transplant 1997, 12, 1109-1115.
32. Toyama-Sorimachi N, Miyasaka M: A novel ligand for CD44 is sulfated proteoglycan. Int Immunol 1994, 6, 655-660.
33. Weber GF, Ashkar S, Glimcher MJ, Cantor H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996, 271, 509-512.
34. Weibel ER: Stereological Methods. Vol 1. Practical Methods for Biological Morphometry. Academic Press, London, New York, Toronto, Sydney, San Francisco 1979, 100-161.
35. Wuthrich RP: The proinflammatory role of hyaluronan-CD44 interactions in renal injury. Nephrol Dial Transplant 1999, 14, 2554-2556.
36. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F: Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 2001, 60, 1645-1657.
37. Zhang G, Morhead PJ, El Nahas AM: Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995, 3, 308-318.